These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9117910)

  • 1. Impact of medical interventions on quality of life in cardiovascular disease: a consensus viewpoint.
    Arnold JM; Sasson Z; Mathias S; Black WR; Gill JB; Higginson L; Huckell V; Klinke P; MacDonald R; Morgan C; Smith E; Tasch RF; Warnica W
    Can J Cardiol; 1997 Mar; 13(3):235-6. PubMed ID: 9117910
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety in clinical trials in cardiovascular disease.
    Cohn JN
    J Am Coll Cardiol; 2006 Aug; 48(3):430-3. PubMed ID: 16875964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse dermatologic effects of cardiovascular drug therapy.
    Brosnan BD; Frishman WH; Sun DK; Grossman M
    Heart Dis; 2000; 2(3):220-47. PubMed ID: 11728264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study on well-being in the very old: the role of cardiovascular diseases and drugs.
    Westerbotn M; Agüero-Torres H; Fastbom J; Hillerås P
    Arch Gerontol Geriatr; 2005; 40(3):287-97. PubMed ID: 15814162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic implications of the gender-specific aspects of cardiovascular disease.
    Regitz-Zagrosek V
    Nat Rev Drug Discov; 2006 May; 5(5):425-38. PubMed ID: 16672926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions in patients with cardiovascular disease. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2008 Dec; 33(12):701. PubMed ID: 19000585
    [No Abstract]   [Full Text] [Related]  

  • 7. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
    Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
    Am J Cardiol; 2005 Jul; 96(2):313-21. PubMed ID: 16018863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and safety of the drug treatment of cardiovascular diseases].
    Mazur NA
    Ter Arkh; 1993; 65(8):4-7. PubMed ID: 8211800
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reactions in patients with cardiovascular disease.
    Faulx MD; Francis GS
    Curr Probl Cardiol; 2008 Dec; 33(12):703-68. PubMed ID: 19000586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ophthalmological manifestations of the side effects of cardiovascular drugs].
    Mozherenkov VP; Kalashev II
    Vestn Oftalmol; 1987; 103(6):58-60. PubMed ID: 3328385
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of pharmaceuticals on the decline of cardiovascular mortality in Germany.
    Häussler B; Schiffhorst G; Gothe H; Hempel E
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1167-76. PubMed ID: 17551995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled intervention in cardiovascular drug treatment in nursing homes.
    Ulfvarson J; Adami J; Ullman B; Wredling R; Reilly M; von Bahr C
    Pharmacoepidemiol Drug Saf; 2003; 12(7):589-93. PubMed ID: 14558182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing common cardiovascular drugs.
    Nursing; 2002 Mar; 32(3):56-7. PubMed ID: 11902048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of cardiovascular diseases in the elderly].
    Kuprash LP
    Med Sestra; 1983 Jan; 42(1):23-6. PubMed ID: 6550159
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of cardiovascular disease in the elderly: a review of the Canadian Cardiovascular Society Consensus Conference.
    Robertson-Laxton L; Furness W
    Nurs Clin North Am; 2004 Dec; 39(4):863-72. PubMed ID: 15561166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of chronic heart failure].
    Watzinger N; Fruhwald FM; Klein W
    Wien Med Wochenschr; 1998; 148(5):128-30, 132-3. PubMed ID: 9654699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular medications.
    Williams S; Wynn G; Cozza K; Sandson NB
    Psychosomatics; 2007; 48(6):537-47. PubMed ID: 18071104
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug-induced vital disorders].
    Erdmann E
    Internist (Berl); 1987 Feb; 28(2):116-22. PubMed ID: 3330064
    [No Abstract]   [Full Text] [Related]  

  • 19. Using measures of disease progression to determine therapeutic effect: a sirens' song.
    Granger CB; McMurray JJ
    J Am Coll Cardiol; 2006 Aug; 48(3):434-7. PubMed ID: 16875965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart and mind: (2) psychotropic and cardiovascular therapeutics.
    Shah SU; Iqbal Z; White A; White S
    Postgrad Med J; 2005 Jan; 81(951):33-40. PubMed ID: 15640426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.